BridgeBio Pharma, Inc.
NASDAQBridgeBio Pharma enters the final stretch before its June 22 earnings with a cluster of insider sales at the top, a dramatic single-day shift in options sentiment, and a short position that — while elevated — has quietly been unwinding. The most striking development this week is a coordinated wave of insider selling from BridgeBio's own leadership. CEO and founder Neil Kumar sold…
Snapshot as of 27 May 2026
BridgeBio Pharma enters the final stretch before its June 22 earnings with a cluster of insider sales at the top, a dramatic single-day shift in options sentiment, and a short position that — while elevated — has…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BBIO — free to start on ORTEX.
Sign up for free →Open BBIO on ORTEX